Acrodermatitis chronica atrophicans (ACA) is a late and chronic manifestation of Lyme borreliosis. If untreated, ACA progresses from an early inflammatory stage to a chronic, atrophic phase, which neuropathy, arthralgias, and cutaneous malignancy can complicate. Due to its insidious onset, the diagnosis of ACA is challenging and often delayed. This activity reviews the evaluation and management of ACA and highlights the role of the interprofessional team in improving care for patients with this condition.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/110339
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Complex General Surgical Oncology, Dermatopathology, General Pediatrics, Infectious Disease, Infectious Diseases/Medical Microbiology, Internal Medicine, Medical Oncology, Pediatric Hematology-Oncology, Pediatric Infectious Diseases
Subscribe
Login
0 Comments
Oldest